Feasibility of continuous temperature monitoring in pediatric immunocompromised patients: A pilot study

Megan Sampson1, Victoria Hickey1, John Huber2

  • 1Division of Bone Marrow Transplantation and Immune Deficiency, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

Insights

Continuous temperature monitoring using TempTraq patches offers a feasible and safe way to detect fever early in immunocompromised children, improving upon standard monitoring methods. This technology aids in timely intervention, potentially reducing severe illness.

Area of Science:

  • Pediatric Medicine
  • Infectious Disease Monitoring
  • Medical Device Technology

Background:

  • Fever detection is critical for managing immunocompromised patients, as delays can increase morbidity and mortality.
  • Current episodic temperature monitoring may not reliably detect or may delay fever identification in this vulnerable population.

Purpose of the Study:

  • To assess the feasibility, safety, and tolerability of continuous temperature monitoring using the TempTraq patch in pediatric patients.
  • To compare the efficacy of continuous monitoring with standard episodic monitoring for fever detection.

Main Methods:

  • A pilot study involving ten pediatric patients.
  • Continuous temperature monitoring was conducted for 5 days using TempTraq patches.
  • Data was compared against standard episodic temperature monitoring (standard of care).

Main Results:

  • TempTraq successfully detected fever in two patients missed by episodic monitoring.
  • Significant delays (>12 hours) in fever detection were observed with episodic monitoring in two cases, which TempTraq identified promptly.
  • Caregivers found the TempTraq patch to be tolerable and easy to apply.

Conclusions:

  • Continuous temperature monitoring with TempTraq is a feasible, safe, and well-tolerated method for pediatric patients.
  • TempTraq demonstrates superior performance in early fever detection compared to standard episodic monitoring in immunocompromised children.
  • This technology holds promise for improving clinical management and outcomes in pediatric patients at risk for febrile episodes.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
212
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
271
Pilot and Numeric Relaying01:21

Pilot and Numeric Relaying

Pilot relaying is a type of differential protection used in power systems. It compares electrical quantities at the terminals of equipment via a communication channel instead of direct relay interconnection. This method is essential for transmission lines where the terminals are far apart, typically up to 80 km for lines with 69 to 115 kV ratings. Four types of communication channels are used for pilot relaying:
487
Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.9K